We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Erectile dysfunction in successfully treated lymphoma patients.
- Authors
Aksoy S; Harputluoglu H; Kilickap S; Dincer M; Dizdar O; Akdogan B; Ozen H; Erman M; Celik I; Aksoy, Sercan; Harputluoglu, Hakan; Kilickap, Saadettin; Dincer, Murat; Dizdar, Omer; Akdogan, Bulent; Ozen, Haluk; Erman, Mustafa; Celik, Ismail
- Abstract
<bold>Background: </bold>Information on male potency in lymphoma survivors is insufficient. In this study, we assessed male sexual function and serum gonadotropins in successfully treated lymphoma patients.<bold>Materials and Methods: </bold>Fifty-nine patients treated for Hodgkin's lymphoma (HL) or non-HL (NHL) with chemotherapy +/- radiotherapy were included in the study.<bold>Results: </bold>The mean age (+/-standard deviation) of the patients was 40.2 +/- 11.0 (range, 18-55 years). Thirty-eight (64.4%) had HL and 21 (35.6%) NHL. According to the International Index of Erectile Function (IIEF) score, 61.0% had some degree of erectile dysfunction (ED; IIEF score < 26): 33.9% had mild ED (IIEF score 17-25), 15.2% moderate ED (IIEF score 11-16), and 11.9% severe ED (IIEF score 6-10). Age distribution was similar in patients with ED and those with normal erectile function. Presence of ED and its grade were not different between HL and NHL patients. Nine (18.4%) of 49 patients had an elevated follicle-stimulating hormone, 7 (14.2%) had elevated luteinizing hormone, and 3 (6.1%) had decreased testosterone levels. These hormonal abnormalities did not affect the presence of ED and its severity.<bold>Conclusions: </bold>Overall, 61.0% of men in our study had ED according to IIEF. Clinicians should be aware of this problem in lymphoma survivors and offer these patients adequate treatment options.
- Publication
Supportive Care in Cancer, 2008, Vol 16, Issue 3, p291
- ISSN
0941-4355
- Publication type
journal article
- DOI
10.1007/s00520-007-0307-y